Skip to main content
ConductScienceScienceDex

Yong Teng

NIH Rank #3105
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 10454881Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • ENGINEERING (ALL TYPES)
  • Internal Medicine

NIH Funding · FY2026

Linked Award Amount
$2M
Full award amounts, FY2026
Award Records
4
Records listing this PI
Award-Linked Rank
#3,105
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Yong Teng. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Yong Teng as a PI. Multi-PI records show the full award amount for context.

  • 1R01DE035487-01R01
    Engineered Synthetic Low-Density Lipoprotein Nanoparticles for Enhanced Cancer Immunotherapy in Head and Neck Cancer
    University of Georgia
    $644.5K
    award amount
  • 1R01CA299080-01A1R01
    Calcium Nanoparticles to Enhance Immuno-Radiotherapy
    University of Georgia
    $618.2K
    award amount
  • 5R01DE033691-03R01
    Inhibiting mitochondrial complex I to improve cetuximab efficacy in oral cancer
    Emory University
    $386.5K
    award amount
  • 5R01DE033433-03R01
    Targeted Arf1 inhibition to enhance immune response in oral cancer
    Emory University
    $371.9K
    award amount

Award organizations

Organizations that administered FY2026 awards listing Yong Teng as a PI.

University of Georgia
GA
$1.3M
2 grants
Emory University
GA
$758.4K
2 grants

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of Georgia
  2. 2024
    $500K Cumulative Funding
  3. 2025
    $1M Cumulative Funding
  4. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  5. 2025
    R01 Grant Holder
  6. 2026
    $2M Cumulative Funding
  7. 2026
    Entered Top 50% Nationally
    Ranked #3105
  8. 2026
    Entered Top 25% Nationally
    Ranked #3105

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Yong Teng.

Jin Xie
University of Georgia
2
shared awards

Explore further

Find collaborators for Yong Teng

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →